The company’s platform allows patients to remotely transfer lung health data to clinicians by blowing into a spirometer. Next, the patient can record symptoms and environmental factors in Aluna’s app, according to a Feb. 1 Aluna news release.
Aluna is used by patients managing their asthma, cystic fibrosis and COPD. The financing round brings the company’s total raised to $27 million.
“As we head into 2023, we plan to grow Aluna’s product and its scale with this funding and the support of our partners,” Aluna COO Jason Hochman said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit